ArticleAlimentary pharmacology & therapeutics2026

Editorial: Risankizumab in Refractory Crohn's Disease-From Real-World Effectiveness to Strategic Positioning and Early Monitoring. Authors' Reply.

Rocio Ferreiro-Iglesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.